Skip to main content
Smart Investors Daily
DM

NASDAQ · DMAQ

Deep Medicine Acquisition Corp.

Financial Services · Shell Companies

$2.96

Down-$5.43 (-64.72%)

Updated Aug 23, 2026, 9:33 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
12.9M
P/E ratio
-0.09
Dividend yield
0.00%
52-week range
— – —
Volume
73.88K
Avg. volume
132.22K

Price performance

DMAQ price history

1M range · 0 trading sessions · Daily adjusted prices

DMAQ does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest DMAQ news

The latest Smart Investors Daily articles mentioning DMAQ.

DMAQ research

Overview

Company profile and research snapshot.

Company profile

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Oct 20, 2022

Deep Medicine Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

New York, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”), announced today that an aggregate of $1,265,000 has been deposited into the Company’s trust account for its public shareholders, representing $0.10 per public share, which enables the Company to extend the period of time it has to consummate its initial business combination by three months from October 29, 2022 to January 29, 2023 (the “Extension”). The Extension is the first of up to two three-month extensions permitted under the Company’s governing documents.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.